Biopharmaceutical company First Wave BioPharma, Inc. (FWBI) announced Wednesday that it has entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis and related conditions to an undisclosed biopharmaceutical company.
First Wave BioPharma, Inc. (FWBI) shares are surging more than 156 percent on Wednesday morning trade after the company announced a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases or IBD to an undisclosed biopharmaceutical company for unspecified financial terms.
Woodbois Limited (LON:WBI – Get Free Report) traded down 1% on Tuesday . The stock traded as low as GBX 0.93 ($0.01) and last traded at GBX 0.97 ($0.01). 64,088,814 shares changed hands during trading, an increase of 102% from the average session volume of 31,717,617 shares. The stock had previously closed at GBX 0.98 […]
New members include the American Society of Interior Designers (ASID), Hines Australia, Goldman Sachs and Rolex Watch USANEW YORK, NY / ACCESSWIRE / October 16, 2023 / The International WELL Building Institute (IWBI) is pleased to announce new organizations .
PM modi table draft amendment bill act preventing animal cruelty monsoon session; letter PM Narendra Modi NGO pending status bill recommendations Animal Welfare Board of India 140 MPs; monsoon session Parliament commence July 20 continue August 11; animal rights organisation written Prime Minister Narendra Modi urging table draft amendment bill Prevention of Cruelty to Animals Act upcoming monsoon session Parliament; letter prime minister Mercy For Animals India Foundation pending status bill recommendations Animal Welfare Board of India 140 MPs; latest news on news18.com; Vijaysinh Parmar